In the context of prostate cancer, BHLHE22 and PRMT5 assemble a transcriptional complex that initiates CSF2 transcription, which then attracts many immunosuppressive neutrophils and monocytes, promoting the tumor’s metastasis to the bones. This evidence concerns the gene CSF2 and Familial prostate cancer.